IRVINE, Calif., Nov. 5, 2005 (PRIMEZONE) -- "A recent USA Today report has highlighted November's historic benevolence to the stock market, denoting that after what is often a cautious October, that 'bullish forces emerge from hibernation and jump-start moneymaking rallies," noted SmallCap Sentinel analyst D.R. Clark. "This could well lead investors into attractive sectors such as biotech where opportunities for potential returns may lay in wait. Investors looking to salvage mediocre years in their portfolios are often more inclined to 'be aggressive' and target possible exponential return equities."
"With biotech mercurial at best over the past few months, investors may find companies that are trading below watermarks at which they would have previously invested but didn't because of overall market sentiment or because it was simply earlier in the year," said Clark. "Factor in the market's traditional verticality in November and it could bode well for sectors like biotech. Many investors looking to 'repair' their portfolios seek companies that they feel can be explosive as to valuation temporarily bypassing the stalwart Fortune 500 companies that appreciate more predictably and conservatively."
An informational report "The Silver Tsunami: Baby Boomers & Biotech Breakthroughs" has been made available free of charge via financial courier StockUpTicks.com at www.SmallCapSentinel.com
The report details various issues affecting the current market for biotechnology companies including Biophan Technologies, Inc. (OTCBB:BIPH), Baxter International Inc. (NYSE:BAX), Intuitive Surgical Inc. (Nasdaq:ISRG), and ev3, Inc. (Nasdaq:EVVV).
Biophan develops visionary technology for the medical device industry. This technology covers several areas including MRI safety and image compatibility, a drug delivery technology based on nanomaterials, a biothermal battery that generates electricity from body heat, and a cardiac assist device, the MYO-VAD, that is non-blood contacting and offers full biventricular, systolic and diastolic support for the heart.
Additional information regarding Biophan is available at: http://trilogy-capital.com/biph_summary.aspx
Individuals may also register for future reports at: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy, nor offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid $1,500 by Biophan for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.